T2 Biosystems, Inc. (TTOO)
| Market Cap | 25.42M |
| Revenue (ttm) | 11.00M |
| Net Income (ttm) | -49.84M |
| Shares Out | 4.05M |
| EPS (ttm) | -157.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 843,707 |
| Open | 7.18 |
| Previous Close | 7.45 |
| Day's Range | 6.10 - 7.72 |
| 52-Week Range | 3.36 - 211.00 |
| Beta | 0.20 |
| Analysts | Hold |
| Price Target | 7.00 (+11.55%) |
| Earnings Date | Nov 15, 2023 |
About TTOO
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood test that identifies blood st... [Read more]
Financial Performance
In 2022, T2 Biosystems's revenue was $22.31 million, a decrease of -20.50% compared to the previous year's $28.06 million. Losses were -$62.33 million, 26.6% more than in 2021.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for TTOO stock is "Hold" and the 12-month stock price forecast is $7.0.
News
What's going on with T2 Biosystems (TTOO) stock?
T2 BioSystems (NASDAQ: TTOO) stock price rose by more than 23% on Tuesday amid a short-squeeze and as some investors bought the dip. The shares jumped to a high of $4.81, its highest point sice mid-No...
T2 Biosystems (TTOO) stock price volatility has died: buy the dip?
T2 Biosystems (NASDAQ: TTOO) stock price has collapsed to a record low as concerns about the company's future continued. Shares of the popular penny stock have collapsed to a split-adjusted low of $4....
T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
LEXINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, toda...
T2 Biosystems Regains Compliance with Nasdaq Listing Requirements
LEXINGTON, Mass., Nov. 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, toda...
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
Data demonstrates speed, accuracy, and clinical benefits of the T2Dx Instrument and T2 Biosystems' sepsis panels, including encouraging early detection data for T2Resistance Panel Data demonstrates sp...
T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the s...
T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
Received FDA 510(k) clearance for the T2Biothreat Panel and significantly strengthened balance sheet Received FDA 510(k) clearance for the T2Biothreat Panel and significantly strengthened balance shee...
T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
LEXINGTON, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that...
T2 Biosystems Announces Reverse Stock Split Effective Today
TTOO common stock expected to begin trading on a split-adjusted basis on October 13, 2023 TTOO common stock expected to begin trading on a split-adjusted basis on October 13, 2023
TTOO stock price: brace for T2 Biosystems volatility after earnings
T2 Biosystems (NASDAQ: TTOO) stock price will be in the spotlight on Thursday as the company publishes its financial results. The shares jumped to a high of $0.3090, a few points above this month's lo...
Top 3 penny stocks to day trade: HUBC, TTOO, NVOS
Penny stocks are highly popular among day and swing traders because of their low prices and volatility. Most of these stocks are usually bad long-term investments because of their unprofitability, esp...
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., Oct. 06, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to n...
T2 Biosystems to Report Preliminary Third Quarter 2023 Financial Results and Business Updates on October 12, 2023
LEXINGTON, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that...
TTOO stock price outlook as big shareholder dumps shares
T2 Biosystems (NASDAQ: TTOO) stock price sell-off continued as the company continued facing numerous headwinds. The shares dropped to a low of $0.1884 on Tuesday, the lowest level since August 2nd.
T2 Biosystems' stock extends losing streak despite FDA approval for anthrax and plague diagnostic test
Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test.
T2 Biosystems reaches regulatory milestone that could be a game changer, analyst says
T2 Biosystems Inc., a Lexington, Mass.-based developer of diagnostics for rapid identification of dangerous pathogens, has reached a key regulatory milestone that could alter its near-term future, acc...
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned company The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned co...
TTOO stock price is flying: How high can T2 Biosystems go?
T2 Biosystems (NASDAQ: TTOO) stock price made a strong comeback during the pre-market session as investors bought the dip. The shares surged by more than 40%, its best daily performance since August.
T2 Biosystems to Participate in the Gilmartin Group Emerging Growth Company Showcase
LEXINGTON, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced pla...
T2 Biosystems Praises CDC's Actions Aimed at Optimizing U.S. Hospital Sepsis Programs
The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core Elements The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core E...
TTOO stock price has recoiled: Is it safe to buy T2 Biosystems?
T2 Biosystems (NASDAQ: TTOO) stock price retreated in the past few weeks as the recent rebound lost momentum. After peaking at $0.6960 this month, the shares have pulled back by ~45% to $0.40, giving ...
T2 Biosystems touts ‘highly differentiated' products in fight against sepsis
T2 Biosystems Inc. is offering “highly differentiated” products in the fight against sepsis, according to CEO John Sperzel.
T2 Biosystems stock falls 12.3% premarket after snapping 3-day winning streak
Shares of micro cap T2 Biosystems Inc. TTOO, -3.77% plunged 12.2% in premarket trades Thursday. The health diagnostics company's stock ended Wednesday's session down 3.8%, snapping a three-day winning...
TTOO's 375% Surge In A Month: Unveiling the Driving Forces
The small-cap penny stock market has been hot lately, with a surge in volume and activity across several names. The most in-play name, with price and volume soaring remarkably, has been T2 Biosystems ...
T2 Biosystems stock climbs more than 4% premarket to continue rally
Shares of micro cap T2 Biosystems Inc. TTOO rose 4.1% in premarket trades Wednesday, continuing their rally. The health diagnostics company's stock ended Monday's session up 51.6% for their highest on...